EUVIMEDEUVIMED entdecken
Open Access

Liraglutide improves cognition function in streptozotocin-induced diabetic rats by downregulating β-secretase and γ-secretase and alleviating oxidative stress in HT-22 cells

Lou-Yan Ma, Song-Fang Liu, Zheng-Quan Ma, Ya-Gang Guo, Mo Li, Yuan Gao, Yu-Ting Wen, Yu Niu, Hai-Xia Sui, Bao-Shan Li, Ya Li, Ya-Li Lv und 2 weitere

Endocrine Journal · 2025

DOI: 10.1507/endocrj.ej23-0723 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrine Journal, 2025. Verfasst von Lou-Yan Ma und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Practice Medicine, Xi'an No. 9 Hospital, Xi'an 710054, China. Hauptthemen laut MEDLINE: Liraglutide, Oxidative Stress, Amyloid Precursor Protein Secretases, Diabetes Mellitus, Experimental. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Research project of Xi'an Municipal Health Commission, Xi’an Science and Technology Plan Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetes has been regarded as an independent risk factor for Alzheimer's disease (AD). Liraglutide could improve cognition in AD mouse models, but its precise mechanism remains unclear. In this study, we used STZ-induced diabetic rats and HT-22 cells to investigate the effects of liraglutide. The MWM test, MTT assay, ELISA, western blot, and immunofluorescence were used in this research. Diabetic rats induced by STZ displayed a longer escape latency and entered the target zone less frequently (p < 0.05) in the MWM test. Intraperitoneal injection of liraglutide improved the cognition of diabetic rats (p < 0.05) and reduced Aβ42 expression in the hippocampus (p < 0.05). In vivo experiments showed that HT-22 cell viability decreased in the HG group, but liraglutide (100 nmol/L and 1 μmol/L) enhanced HT-22 cell viability (p < 0.05). Oxidative stress markers were upregulated in HT-22 cells in the HG group, while liraglutide treatment significantly reduced these markers (p < 0.05). Western blot and immunofluorescence analyses demonstrated increased levels of Aβ, BACE1, and γ-secretase in HT-22 cells in the HG group (p < 0.05), whereas these levels were reduced in the liraglutide treatment group (p < 0.05). These effects were reversed by the nuclear factor kappa B (NF-κB) and extracellular signal-regulated kinase 1/2 (ERK1/2) inhibitors (p < 0.05). These findings suggest that liraglutide improved the cognition of diabetic rats and might exert its protective effects by reducing oxidative stress, downregulating BACE1 and γ-secretase expression, and decreasing Aβ deposition via the NF-κB and ERK1/2 pathways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LiraglutideOxidative StressAmyloid Precursor Protein SecretasesDiabetes Mellitus, ExperimentalCognitionHypoglycemic AgentsAnimalsRatsMaleHippocampusDown-RegulationAmyloid beta-PeptidesCell LineRats, Sprague-DawleyAspartic Acid EndopeptidasesCell Survival

Stichwörter der Autor:innen

AmyloidBACE1DiabetesLiraglutideγ-secretase

Substanzen

LiraglutideAmyloid Precursor Protein SecretasesAmyloid beta-PeptidesAspartic Acid EndopeptidasesHypoglycemic AgentsBace1 protein, rat

Autor:innen und Institutionen

  • Department of General Practice Medicine, Xi'an No. 9 Hospital, Xi'an 710054, China.
  • Department of Endocrinology, Xi'an No. 9 Hospital, Xi'an 710054, China.
  • Department of Clinical Laboratory, Xi'an No. 9 Hospital, Xi'an 710054, China.
  • Department of Pathology, Xi'an No. 9 Hospital, Xi'an 710054, China.
  • Department of Neurology, Hejian People's Hospital, Hejian 062450, China.
  • Department of Geriatrics, Chongqing Emergency Medical Center, Chongqing 400014, China.

Förderung

  • National Natural Science Foundation of China
  • Research project of Xi'an Municipal Health Commission
  • Xi’an Science and Technology Plan Project

Zitieren

APA

Ma, L. Y., Liu, S. F., Ma, Z. Q., Guo, Y. G., Li, M., Gao, Y., Wen, Y. T., Niu, Y., Sui, H. X., Li, B. S., Li, Y., Lv, Y. L., Huang, Y., & Zhai, J. J. (2025). Liraglutide improves cognition function in streptozotocin-induced diabetic rats by downregulating β-secretase and γ-secretase and alleviating oxidative stress in HT-22 cells. Endocrine Journal. https://doi.org/10.1507/endocrj.ej23-0723

Vancouver

Ma LY, Liu SF, Ma ZQ, Guo YG, Li M, Gao Y, et al. Liraglutide improves cognition function in streptozotocin-induced diabetic rats by downregulating β-secretase and γ-secretase and alleviating oxidative stress in HT-22 cells. Endocrine Journal. 2025. doi:10.1507/endocrj.ej23-0723

BibTeX
@article{Ma2025,
  author = {Ma, Lou-Yan and Liu, Song-Fang and Ma, Zheng-Quan and Guo, Ya-Gang and Li, Mo and Gao, Yuan and Wen, Yu-Ting and Niu, Yu and Sui, Hai-Xia and Li, Bao-Shan and Li, Ya and Lv, Ya-Li and Huang, Yao and Zhai, Jia-Jia},
  title = {Liraglutide improves cognition function in streptozotocin-induced diabetic rats by downregulating β-secretase and γ-secretase and alleviating oxidative stress in HT-22 cells},
  journal = {Endocrine Journal},
  year = {2025},
  doi = {10.1507/endocrj.ej23-0723}
}
Kostenlos starten →